適用於公開取用強制性政策的文章 - Panagiotis Antiochos瞭解詳情
在某個資料庫公開的文章：28
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population
P Antiochos, P Marques-Vidal, J Virzi, S Pagano, N Satta, F Bastardot, ...
Thrombosis and haemostasis 116 (10), 764-771, 2016
授權規定： Swiss National Science Foundation
Imaging of clinically unrecognized myocardial fibrosis in patients with suspected coronary artery disease
P Antiochos, Y Ge, K Steel, S Bingham, S Abdullah, JR Mikolich, AE Arai, ...
Journal of the American College of Cardiology 76 (8), 945-957, 2020
授權規定： Swiss National Science Foundation, US National Institutes of Health
Association between parental history and genetic risk scores for coronary heart disease prediction: The population-based CoLaus study
P Antiochos, P Marques-Vidal, A McDaid, G Waeber, P Vollenweider
Atherosclerosis 244, 59-65, 2016
授權規定： Swiss National Science Foundation
Anti-apolipoprotein A-1 IgG predict all-cause mortality and are associated with Fc receptor-like 3 polymorphisms
P Antiochos, P Marques-Vidal, J Virzi, S Pagano, N Satta, O Hartley, ...
Frontiers in immunology 8, 437, 2017
授權規定： Swiss National Science Foundation
Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IgG-related coronary artery disease prediction in the general population
P Antiochos, P Marques-Vidal, J Virzi, S Pagano, N Satta, O Hartley, ...
Arteriosclerosis, thrombosis, and vascular biology 37 (12), 2342-2349, 2017
授權規定： Swiss National Science Foundation
Evaluation of stress cardiac magnetic resonance imaging in risk reclassification of patients with suspected coronary artery disease
P Antiochos, Y Ge, K Steel, YY Chen, S Bingham, S Abdullah, JR Mikolich, ...
JAMA cardiology 5 (12), 1401-1409, 2020
授權規定： Swiss National Science Foundation, US National Institutes of Health
Stress CMR in patients with obesity: insights from the Stress CMR Perfusion Imaging in the United States (SPINS) registry
Y Ge, K Steel, P Antiochos, S Bingham, S Abdullah, JR Mikolich, AE Arai, ...
European Heart Journal-Cardiovascular Imaging 22 (5), 518-527, 2021
授權規定： Swiss National Science Foundation, US National Institutes of Health
Cost-minimization analysis for cardiac revascularization in 12 health care systems based on the EuroCMR/SPINS registries
K Moschetti, RY Kwong, SE Petersen, M Lombardi, J Garot, D Atar, ...
Cardiovascular Imaging 15 (4), 607-625, 2022
授權規定： Swiss National Science Foundation
Prognostic value of stress CMR perfusion imaging in patients with reduced left ventricular function
Y Ge, P Antiochos, K Steel, S Bingham, S Abdullah, YY Chen, JR Mikolich, ...
Cardiovascular Imaging 13 (10), 2132-2145, 2020
授權規定： Swiss National Science Foundation, US National Institutes of Health
Five year trends in dyslipidaemia prevalence and management in Switzerland: the CoLaus study
P Antiochos, P Marques-Vidal, G Waeber, P Vollenweider
Nutrition, Metabolism and Cardiovascular Diseases 25 (11), 1007-1015, 2015
授權規定： Swiss National Science Foundation
Prognostic value of stress cardiac magnetic resonance in patients with known coronary artery disease
P Antiochos, Y Ge, B Heydari, K Steel, S Bingham, SM Abdullah, ...
Cardiovascular Imaging 15 (1), 60-71, 2022
授權規定： Swiss National Science Foundation, US National Institutes of Health
3-dimensional strain analysis of hypertrophic cardiomyopathy: insights from the NHLBI International HCM Registry
B Heydari, A Satriano, M Jerosch-Herold, P Kolm, DY Kim, K Cheng, ...
Cardiovascular Imaging 16 (4), 478-491, 2023
授權規定： Swiss National Science Foundation, US National Institutes of Health, British …
Prognostic value of pulse pressure after an acute coronary syndrome
B Harbaoui, D Nanchen, P Lantelme, B Gencer, D Heg, R Klingenberg, ...
Atherosclerosis 277, 219-226, 2018
授權規定： Swiss National Science Foundation
Cardiovascular morphometry with high-resolution 3D magnetic resonance: first application to left ventricle diastolic dysfunction
D Gallo, O Vardoulis, P Monney, D Piccini, P Antiochos, J Schwitter, ...
Medical engineering & physics 47, 64-71, 2017
授權規定： Swiss National Science Foundation
Real-world use and predictors of response to disopyramide in patients with obstructive hypertrophic cardiomyopathy
N Maurizi, C Chiriatti, C Fumagalli, M Targetti, S Passantino, P Antiochos, ...
Journal of Clinical Medicine 12 (7), 2725, 2023
授權規定： European Commission
Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases
DC Benz, C Gräni, P Antiochos, B Heydari, MC Gissler, Y Ge, SAM Cuddy, ...
European heart journal 44 (45), 4738-4747, 2023
授權規定： Swiss National Science Foundation
Entropy as a measure of myocardial tissue heterogeneity in patients with ventricular arrhythmias
P Antiochos, Y Ge, RJ van der Geest, C Madamanchi, I Qamar, A Seno, ...
Cardiovascular Imaging 15 (5), 783-792, 2022
授權規定： Swiss National Science Foundation
Prognostic value of T1 mapping and feature tracking by cardiac magnetic resonance in patients with signs and symptoms suspecting heart failure and no clinical evidence of …
A Seno, P Antiochos, H Lichtenfeld, E Rickers, I Qamar, Y Ge, ...
Journal of the American Heart Association 11 (2), e020981, 2022
授權規定： Swiss National Science Foundation
Association of activity behaviours and patterns with cardiovascular risk factors in Swiss middle-aged adults: the CoLaus study
C Gubelmann, P Antiochos, P Vollenweider, P Marques-Vidal
Preventive medicine reports 11, 31-36, 2018
授權規定： Swiss National Science Foundation
Lifetime clinical course of hypertrophic cardiomyopathy: outcome of the historical Florence cohort over 5 decades
N Maurizi, I Olivotto, MS Maron, G Bonacchi, P Antiochos, B Tomberli, ...
JACC: Advances 2 (4), 100337, 2023
授權規定： European Commission
出版品和資金資訊是由電腦程式自動估算而得